A 54-year-old man with type 1 diabetes mellitus (T1DM) on insulin (humalog 25/35 units subcutaneous every AM/PM), albiglutide 50 mg, and canagliflozin 300 mg PO daily developed abdominal pain, nausea, and vomiting. This evidence concerns the gene INS and type 1 diabetes mellitus.